lobbying_activities: 3014673
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3014673 | 524765e7-fb25-4e2f-b15d-cf63a82e9d8c | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | FERA PHARMACEUTICALS, LLC | 2023 | second_quarter | PHA | Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2023-07-19T11:37:56-04:00 |